$0.5200
0.02144.29%
最終更新: Oct 21, 8:45 AM
$0.5067
0.00811.62%
Benzinga
Benzinga
Benzinga
水曜日, 10 21
Benzinga
© 2026 Benzinga | All Rights Reserved
Ensysce Biosciences (ENSC) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-0.50 | $-0.73 | $-1.26 | $-0.90 |
| Actual | $-0.20 | $-0.52 | $-0.75 | $-1.29 |
| Surprise | +60.0% | +28.8% | +40.5% | -43.3% |
| Revenue | ||||
| Estimate | $994000 | $1.9M | $500000 | $1.4M |
| Actual | $1.2M | $960999 | $1.9M | $493104 |
| Surprise | +17.1% | -49.4% | +276.4% | -64.8% |
| Metric | Q3 '26E | Q4 '26E |
|---|---|---|
| Earnings Per Share (Non-GAAP) | ||
| Consensus | $-0.19 | $-0.18 |
| Revenue | ||
| Consensus | $1.2M | $1.2M |
| 会計四半期 | 報告日 | 実質EPS | 推定EPS | 驚き ％ |
|---|---|---|---|---|
| Q2 | Aug 13, 2026 | $-0.20 | $-0.50 | 60.0 % |
| Q1 | May 15, 2026 | $-0.52 | $-0.73 | 28.8 % |
| Q4 | Mar 30, 2026 | $-0.75 | $-1.26 | 40.5 % |
| Q3 | Nov 14, 2025 | $-1.29 | $-0.90 | -43.3 % |
| 会計四半期 | 報告日 | 実際の収益 | 推定収益 | 驚き ％ |
|---|---|---|---|---|
| Q2 | Aug 13, 2026 | $1.16M | $994.00K | 17.1 % |
| Q1 | May 15, 2026 | $961.00K | $1.90M | -49.4 % |
| Q4 | Mar 30, 2026 | $1.88M | $500.00K | 276.4 % |
| Q3 | Nov 14, 2025 | $493.10K | $1.40M | -64.8 % |